Mohs显微摄影手术联合辅助放疗治疗乳腺外Paget病87例回顾性研究

IF 2.7 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Min Zhang, Xianshu Gao, Tianjing Gao, Hang Li, Xueqing Sheng, Mengmeng Su, Chenghao Jia
{"title":"Mohs显微摄影手术联合辅助放疗治疗乳腺外Paget病87例回顾性研究","authors":"Min Zhang, Xianshu Gao, Tianjing Gao, Hang Li, Xueqing Sheng, Mengmeng Su, Chenghao Jia","doi":"10.1093/postmj/qgaf109","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>This retrospective study assessed the effectiveness of Mohs micrographic surgery (MMS) combined with adjuvant radiotherapy for the treatment of extramammary Paget's disease (EMPD).</p><p><strong>Methods: </strong>This retrospective study included 87 patients with pathologically confirmed EMPD and complete follow-up data who were treated at the Radiation Therapy Department of Peking University First Hospital between January 2012 and December 2021. The surgical approach for the primary lesion involved MMS, followed by postoperative radiotherapy with doses ranging from 50 to 60 Gy administered over 25-30 fractions. Lymph node dissection was performed on selected patients exhibiting clinical lymphatic metastasis. The primary endpoint of this study was the disease-specific survival (DSS) rate, while secondary endpoints included local recurrence-free survival (LRFS). Survival rates were calculated using the Kaplan-Meier method and statistically analyzed using the log-rank test.</p><p><strong>Results: </strong>The study population comprised 78 men and 9 women. The median age was 65 years (range: 44-84). The median follow-up period was 71 months (range: 5-139). The 1-, 3-, 5-, and 10-year DSS rates were 99%, 95%, 92%, and 92%, respectively. The LRFS rates at 1, 3, 5, and 10 years were 100%, 100%, 97%, and 94%, respectively. The LNM rates at 1, 3, 5, and 10 years were 1.1%, 2.3%, 5.7%, and 5.7%, respectively. The DM rates at 1, 3, 5, and 10 years were 1.1%, 5.7%, 8.0%, and 9.2%, respectively.</p><p><strong>Conclusion: </strong>The combination of MMS and adjuvant radiotherapy offers excellent local control in the treatment of extramammary Paget's disease. Key messages What is already known on this topic: Surgical excision is the established primary treatment for extramammary Paget's Disease (EMPD). However, the role of adjuvant radiotherapy in improving outcomes was not definitively established. What this study adds: This study provides robust evidence that adjuvant radiotherapy combined with surgical excision significantly improves local disease control rates in EMPD compared to surgery alone. How this study might affect practice: These findings strongly support the integration of adjuvant radiotherapy into the standard management paradigm for EMPD, particularly for cases with risk factors for local recurrence.</p>","PeriodicalId":20374,"journal":{"name":"Postgraduate Medical Journal","volume":" ","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A retrospective study on Mohs micrographic surgery combined with adjuvant radiotherapy in the treatment of extramammary Paget's disease: analysis of 87 patients.\",\"authors\":\"Min Zhang, Xianshu Gao, Tianjing Gao, Hang Li, Xueqing Sheng, Mengmeng Su, Chenghao Jia\",\"doi\":\"10.1093/postmj/qgaf109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>This retrospective study assessed the effectiveness of Mohs micrographic surgery (MMS) combined with adjuvant radiotherapy for the treatment of extramammary Paget's disease (EMPD).</p><p><strong>Methods: </strong>This retrospective study included 87 patients with pathologically confirmed EMPD and complete follow-up data who were treated at the Radiation Therapy Department of Peking University First Hospital between January 2012 and December 2021. The surgical approach for the primary lesion involved MMS, followed by postoperative radiotherapy with doses ranging from 50 to 60 Gy administered over 25-30 fractions. Lymph node dissection was performed on selected patients exhibiting clinical lymphatic metastasis. The primary endpoint of this study was the disease-specific survival (DSS) rate, while secondary endpoints included local recurrence-free survival (LRFS). Survival rates were calculated using the Kaplan-Meier method and statistically analyzed using the log-rank test.</p><p><strong>Results: </strong>The study population comprised 78 men and 9 women. The median age was 65 years (range: 44-84). The median follow-up period was 71 months (range: 5-139). The 1-, 3-, 5-, and 10-year DSS rates were 99%, 95%, 92%, and 92%, respectively. The LRFS rates at 1, 3, 5, and 10 years were 100%, 100%, 97%, and 94%, respectively. The LNM rates at 1, 3, 5, and 10 years were 1.1%, 2.3%, 5.7%, and 5.7%, respectively. The DM rates at 1, 3, 5, and 10 years were 1.1%, 5.7%, 8.0%, and 9.2%, respectively.</p><p><strong>Conclusion: </strong>The combination of MMS and adjuvant radiotherapy offers excellent local control in the treatment of extramammary Paget's disease. Key messages What is already known on this topic: Surgical excision is the established primary treatment for extramammary Paget's Disease (EMPD). However, the role of adjuvant radiotherapy in improving outcomes was not definitively established. What this study adds: This study provides robust evidence that adjuvant radiotherapy combined with surgical excision significantly improves local disease control rates in EMPD compared to surgery alone. How this study might affect practice: These findings strongly support the integration of adjuvant radiotherapy into the standard management paradigm for EMPD, particularly for cases with risk factors for local recurrence.</p>\",\"PeriodicalId\":20374,\"journal\":{\"name\":\"Postgraduate Medical Journal\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-09-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Postgraduate Medical Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/postmj/qgaf109\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Postgraduate Medical Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/postmj/qgaf109","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

摘要

目的:回顾性研究Mohs显微摄影手术(MMS)联合辅助放疗治疗乳腺外Paget病(EMPD)的疗效。方法:回顾性研究2012年1月至2021年12月在北京大学第一医院放射治疗科接受治疗的87例经病理证实的EMPD患者,随访资料完整。原发性病变的手术方法涉及MMS,随后进行术后放疗,剂量从50到60 Gy不等,分25-30次给予。对有临床淋巴结转移的患者进行淋巴结清扫。该研究的主要终点是疾病特异性生存(DSS)率,次要终点包括局部无复发生存(LRFS)。生存率采用Kaplan-Meier法计算,采用log-rank检验进行统计学分析。结果:研究人群包括78名男性和9名女性。中位年龄为65岁(范围:44-84岁)。中位随访期为71个月(范围:5-139)。1年、3年、5年和10年DSS分别为99%、95%、92%和92%。1年、3年、5年和10年的LRFS分别为100%、100%、97%和94%。1年、3年、5年和10年的LNM率分别为1.1%、2.3%、5.7%和5.7%。1年、3年、5年和10年DM患病率分别为1.1%、5.7%、8.0%和9.2%。结论:MMS联合辅助放疗治疗乳腺外Paget病具有良好的局部控制性。关于该主题的已知信息:手术切除是乳腺外佩吉特病(EMPD)的既定主要治疗方法。然而,辅助放疗在改善预后方面的作用尚未明确确立。本研究补充:本研究提供了强有力的证据,与单纯手术相比,辅助放疗联合手术切除可显著提高EMPD的局部疾病控制率。这项研究如何影响实践:这些发现强烈支持将辅助放疗纳入EMPD的标准管理范例,特别是对于有局部复发危险因素的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A retrospective study on Mohs micrographic surgery combined with adjuvant radiotherapy in the treatment of extramammary Paget's disease: analysis of 87 patients.

Purpose: This retrospective study assessed the effectiveness of Mohs micrographic surgery (MMS) combined with adjuvant radiotherapy for the treatment of extramammary Paget's disease (EMPD).

Methods: This retrospective study included 87 patients with pathologically confirmed EMPD and complete follow-up data who were treated at the Radiation Therapy Department of Peking University First Hospital between January 2012 and December 2021. The surgical approach for the primary lesion involved MMS, followed by postoperative radiotherapy with doses ranging from 50 to 60 Gy administered over 25-30 fractions. Lymph node dissection was performed on selected patients exhibiting clinical lymphatic metastasis. The primary endpoint of this study was the disease-specific survival (DSS) rate, while secondary endpoints included local recurrence-free survival (LRFS). Survival rates were calculated using the Kaplan-Meier method and statistically analyzed using the log-rank test.

Results: The study population comprised 78 men and 9 women. The median age was 65 years (range: 44-84). The median follow-up period was 71 months (range: 5-139). The 1-, 3-, 5-, and 10-year DSS rates were 99%, 95%, 92%, and 92%, respectively. The LRFS rates at 1, 3, 5, and 10 years were 100%, 100%, 97%, and 94%, respectively. The LNM rates at 1, 3, 5, and 10 years were 1.1%, 2.3%, 5.7%, and 5.7%, respectively. The DM rates at 1, 3, 5, and 10 years were 1.1%, 5.7%, 8.0%, and 9.2%, respectively.

Conclusion: The combination of MMS and adjuvant radiotherapy offers excellent local control in the treatment of extramammary Paget's disease. Key messages What is already known on this topic: Surgical excision is the established primary treatment for extramammary Paget's Disease (EMPD). However, the role of adjuvant radiotherapy in improving outcomes was not definitively established. What this study adds: This study provides robust evidence that adjuvant radiotherapy combined with surgical excision significantly improves local disease control rates in EMPD compared to surgery alone. How this study might affect practice: These findings strongly support the integration of adjuvant radiotherapy into the standard management paradigm for EMPD, particularly for cases with risk factors for local recurrence.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Postgraduate Medical Journal
Postgraduate Medical Journal 医学-医学:内科
CiteScore
8.50
自引率
2.00%
发文量
131
审稿时长
2.5 months
期刊介绍: Postgraduate Medical Journal is a peer reviewed journal published on behalf of the Fellowship of Postgraduate Medicine. The journal aims to support junior doctors and their teachers and contribute to the continuing professional development of all doctors by publishing papers on a wide range of topics relevant to the practicing clinician and teacher. Papers published in PMJ include those that focus on core competencies; that describe current practice and new developments in all branches of medicine; that describe relevance and impact of translational research on clinical practice; that provide background relevant to examinations; and papers on medical education and medical education research. PMJ supports CPD by providing the opportunity for doctors to publish many types of articles including original clinical research; reviews; quality improvement reports; editorials, and correspondence on clinical matters.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信